Transurethral microwave thermotherapy v sham treatment: double-blind randomized study.

Transurethral microwave thermotherapy (TUMT) is a single-session, 1-hour office-based treatment for benign prostatic hyperplasia. A randomized, double-blind study has been conducted at our institutions involving 115 patients who, after satisfying the entry criteria, were randomized in a 2:1 fashion to receive TUMT or a sham treatment. Three months' unblinding revealed both statistically and clinically significant improvement in the efficacy measures for the real treatment compared with the sham. The mean Madsen Symptom Score decreased 55% and the mean peak flow rate increased 58% in the TUMT-treated patients v 28% and 27% in the sham-treated patients (P < 0.001). Also, the TUMT-treated patients improved in mean AUA Symptom Score by 43% v 26% for sham-treated patients (P < 0.01). Reclassification of patients after therapy showed a greater shift to the mild category of AUA Symptom Score: 37% for TUMT patients v 6.5% for sham-treated patients. In addition, prostate-specific antigen elevation to >4 times baseline was noted 1 week after TUMT v no statistically significant change for sham-treated patients. This double-blind study demonstrates that thermotherapy's efficacy is not placebo related and that the mechanism of action is related to thermal ablation of transition zone adenoma.

[1]  C. C. Chen,et al.  Natural history of prostatism: urinary flow rates in a community-based study. , 1993, The Journal of urology.

[2]  K McPherson,et al.  Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. , 1989, The New England journal of medicine.

[3]  C. Ogden,et al.  Sham versus transurethral microwave thermotherapy in patients with symptoms of benign prostatic bladder outflow obstruction , 1993, The Lancet.

[4]  M. Fall,et al.  Transurethral microwave thermotherapy versus transurethral resection for benign prostatic hyperplasia: preliminary results of a randomized study. , 1993, European urology.

[5]  M. Barry,et al.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. , 1992, The Journal of urology.

[6]  P. Zimmern,et al.  [Transurethral incision of the prostate: an objective and subjective evaluation of long-term efficacy]. , 1993, Journal d'urologie.

[7]  H. Lepor,et al.  Randomized double-blind study comparing the effectiveness of balloon dilation of the prostate and cystoscopy for the treatment of symptomatic benign prostatic hyperplasia. , 1992, The Journal of urology.

[8]  S. St. C. Carter,et al.  Single-Session Transurethral Microwave Thermotherapy for the Treatment of Benign Prostatic Obstruction* , 1991 .

[9]  G. Andriole,et al.  The effect of finasteride in men with benign prostatic hyperplasia. , 1992, The Journal of urology.

[10]  H. Lepor,et al.  A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. , 1992, The Journal of urology.

[11]  M. Devonec,et al.  Transurethral microwave heating of the prostate ― or from hyperthermia to thermotherapy , 1991 .

[12]  J. Lynch,et al.  Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: results of the United States Prostatron Cooperative Study. , 1993, The Journal of urology.